World's Best Scientists 2026 revealed!
Award Badge
Medicine
Germany
2026

D-Index & Metrics

Medicine

D-Index
154
Citations
117181
World Ranking
986
National Ranking
47

Research.com Recognitions

  • 2026 - Research.com Medicine in Germany Leader Award
  • 2023 - Research.com Medicine in Germany Leader Award

Overview

Gerd R. Burmester is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily focuses on medicine, with a substantial body of work in the fields of rheumatology, hematology, immunology, genetics, and pathology and forensic medicine.

The scientist's recent publications reflect involvement in autoimmune and inflammatory disorders, chronic lymphocytic leukemia, and rheumatoid arthritis research. Notable papers include:

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update (2020, Annals of the Rheumatic Diseases)
  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update (2022, Annals of the Rheumatic Diseases)
  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update (2020, Annals of the Rheumatic Diseases)
  • The etiology of rheumatoid arthritis (2020, Journal of Autoimmunity)
  • Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus (2020, New England Journal of Medicine)

Frequent co-authors include:

  • Yoshiya Tanaka
  • Kevin Winthrop
  • Daniel Aletaha
  • Tsutomu Takeuchi
  • Robert Biesen

Burmester's work has been published extensively in several venues, with the most frequent being:

  • Annals of the Rheumatic Diseases (106 publications)
  • RMD Open (23 publications)
  • Lara D. Veeken (22 publications)
  • Revue du Rhumatisme (19 publications)
  • Rheumatology and Therapy (15 publications)

Their research covers multiple topics, showing a broad impact across autoimmune and inflammatory disorders as well as hematological malignancies:

  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Chronic Lymphocytic Leukemia Research
  • Systemic Lupus Erythematosus Research
  • Biosimilars and Bioanalytical Methods
  • Spondyloarthritis Studies and Treatments
  • Lymphoma Diagnosis and Treatment

This profile highlights a comprehensive engagement in various subfields of medicine, documenting a significant contribution to rheumatology and allied disciplines.

Best Publications

  • 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

    Daniel Aletaha;Tuhina Neogi;Alan J. Silman;Julia Funovits

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • Treating rheumatoid arthritis to target: recommendations of an international task force

    Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados

  • Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy : Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

    Stanley B Cohen;Paul Emery;Maria W Greenwald;Maxime Dougados

  • Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

    Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk

  • Guidelines for musculoskeletal ultrasound in rheumatology

    Backhaus M;Burmester Gr;Gerber T;Grassi W

  • Macrophages in rheumatoid arthritis

    Raimund W Kinne;Rolf Bräuer;Bruno Stuhlmüller;Ernesta Palombo-Kinne

  • Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.

    Thomas J Schnitzer;Gerd R Burmester;Eduardo Mysler;Marc C Hochberg

  • Novel treatment strategies in rheumatoid arthritis

    Gerd R Burmester;Janet E Pope

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

    Laure Gossec;Xenofon Baraliakos;Andreas Kerschbaumer;Maarten de Wit

  • European S3-guidelines on the systemic treatment of psoriasis vulgaris

    D Pathirana;AD Ormerod;P Saiag;Catherine Smith

  • Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging.

    M. Backhaus;T. Kamradt;D. Sandrock;D. Loreck

  • Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

    Christian E. Antoni;Arthur Kavanaugh;Bruce Kirkham;Zuhre Tutuncu

  • Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

    Gerd R Burmester;Ricardo Blanco;Christina Charles-Schoeman;Jürgen Wollenhaupt

  • Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus.

    Marcus Odendahl;Annett Jacobi;Arne Hansen;Eugen Feist

  • Synovitis score: discrimination between chronic low-grade and high-grade synovitis

    V. Krenn;L. Morawietz;G.-R. Burmester;R. W. Kinne

  • Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease

    Gerd R Burmester;Remo Panaccione;Kenneth B Gordon;Melissa J McIlraith

  • Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

    Michael E. Farkouh;Howard Kirshner;Robert A. Harrington;Sean Ruland

  • Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

    Antonio Naranjo;Tuulikki Sokka;Miguel A. Descalzo;Jaime Calvo-Alén

Frequent Co-Authors

Josef S. Smolen
Josef S. Smolen Medical University of Vienna
Paul Emery
Paul Emery University of Leeds
Thomas Dörner
Thomas Dörner Charité - University Medicine Berlin
Bernard Combe
Bernard Combe University of Montpellier
Maxime Dougados
Maxime Dougados Hôpital Cochin
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Falk Hiepe
Falk Hiepe Charité - University Medicine Berlin
Ronald F. van Vollenhoven
Ronald F. van Vollenhoven University of Amsterdam
Thomas Häupl
Thomas Häupl Charité - University Medicine Berlin
Mark C. Genovese
Mark C. Genovese Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can provide more flexibility for those interested in medical and nursing careers, especially if you’re balancing other commitments. For registered nurses aiming to enhance their qualifications without intensive on-site requirements, rn to bsn programs without clinicals offer a convenient path to earn a BSN degree entirely online. This can be ideal for working professionals or those with family obligations.

Many students also look for ways to advance their careers quickly and affordably. If you already have a nursing master’s degree, finding the shortest msn to dnp program can fast-track you toward a Doctor of Nursing Practice qualification. For those focused on cost, seeking out the cheapest dnp programs available online can make advanced study more accessible without sacrificing quality.

Not ready for a lengthy commitment? Start quickly in healthcare by considering what is the fastest way to become an lpn. Fast-track online LPN programs offer accelerated routes for entry into the field, opening doors to rewarding patient care positions in less time.

Best Scientists Citing Gerd R. Burmester

Trending Scientists

Recently Published Articles